Nesta página
DXCM DexCom, Inc. - Common Stock
NASDAQ · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Jul 30, 2026
$85,36
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$54,11mínima 52 sem
$92,59máxima 52 sem
Capitalização de Mercado (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Receita (TTM)
$4.97B
seus distintivos
Intervalo 52 Semanas
$54–$93
Classificação do Analista
BUY
Preço-Alvo
$95
P/E
33.9
ROE
38.5%
Margem de Lucro Líquido
20.1%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
DXCM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$85.36
Capitalização de Mercado (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Receita (TTM)
$4.97B
ROE (TTM)
38.5%
Intervalo 52 Semanas
$54–$93
DXCM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 13 de Junho de 2022 | 4-for-1 | Para frente |
Sobre DexCom, Inc. - Common Stock Visão geral da empresa da Wikipedia
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários11.000
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$4.66B2016-12-31 → 2025-12-31
EPS$2.092017-12-31 → 2025-12-31
Fluxo de caixa livre$1.08B2016-12-31 → 2025-12-31
Margem líquida20.1%2018-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | DXCM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 33.9média 5A ≈114.7 | ≈114.7 | 28.0 | Valor justo | |
| P/S (TTM) | 6.5média 5A ≈9.3 | ≈9.3 | 4.8 | Sobreavaliado | |
| P/B (MRQ) | 12.3média 5A ≈14.6 | ≈14.6 | 4.7 | Sobreavaliado | |
| Preço / FCF (TTM) | 22.9média 5A ≈110.6 | ≈110.6 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 18.4média 5A ≈41.4 | ≈41.4 | 21.9 | Subvalorizado | |
| Preço / Valor Patrimonial Tangível (MRQ) | 12.8média 5A ≈15.9 | ≈15.9 | · | · | |
| PEG Ratio | ≈3.6 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | DXCM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 62.5%média 5A ≈63.4% | ≈63.4% | 64.0% | Fraco | |
| Margem Operacional (TTM) | 22.9%média 5A ≈15.0% | ≈15.0% | 23.0% | Em linha | |
| Margem EBITDA (TTM) | 28.2%média 5A ≈20.1% | ≈20.1% | 27.1% | Em linha | |
| Margem de Impostos Pré-Tributação (TTM) | 25.8%média 5A ≈16.2% | ≈16.2% | 21.6% | Em linha | |
| Margem de Lucro Líquido (TTM) | 20.1%média 5A ≈13.0% | ≈13.0% | 15.3% | Primeira linha | |
| ROA (TTM) | 14.5%média 5A ≈8.3% | ≈8.3% | 7.5% | Primeira linha | |
| ROE (TTM) | 38.5%média 5A ≈21.9% | ≈21.9% | 14.1% | Primeira linha | |
| ROIC | 25.5%média 5A ≈19.4% | ≈19.4% | 9.9% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | DXCM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 1.7média 5A ≈2.7 | ≈2.7 | 1.5 | Em linha | |
| Quick Ratio (Índice de Liquidez Seca) | 1.0média 5A ≈1.1 | ≈1.1 | 0.8 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | DXCM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 15.6%média 5A ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 17.0%média 5A ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 19.3% | · | · | · | |
| EPS YoY | 47.2%média 5A ≈21.9% | ≈21.9% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | 45.1%média 5A ≈21.4% | ≈21.4% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 36.6%média 5A ≈24.9% | ≈24.9% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | 9.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 34.8%média 5A ≈24.3% | ≈24.3% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | 8.8% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | DXCM | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.7média 5A ≈0.6 | ≈0.6 | 0.5 | Primeira linha | |
| Inventory Turnover (Giro de Estoque) | 3.2média 5A ≈3.0 | ≈3.0 | 2.4 | Primeira linha | |
| Receivables Turnover (Giro de Contas a Receber) | 4.2média 5A ≈4.5 | ≈4.5 | 6.1 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$423.8K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
9.1%
Próximo relatório
Out 28, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 28, 2026 | $0.70 | $0.62 | 12.4% |
| 31 de Março de 2026 | $0.56 | $0.48 | 17.0% | |
| 31 de Dezembro de 2025 | $0.56 | $0.48 | 17.0% | |
| 30 de Setembro de 2025 | $0.61 | $0.58 | 5.3% | |
| 30 de Junho de 2025 | $0.48 | $0.45 | 6.8% | |
| 31 de Março de 2025 | $0.32 | $0.33 | -4.1% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.14 | $5.38 | $5.37 | $5.52 | $23.21 | $19.01 | $9.64 | $7.37 | $4.82 | $3.35 | $2.71 | $1.81 | |
| Revenue / Share | $11.50 | $9.77 | $8.51 | $6.81 | $24.46 | $19.76 | $15.99 | · | · | · | · | · | |
| Cash Flow / Share | $3.55 | $2.40 | $1.76 | $1.57 | $4.42 | $4.88 | $3.41 | · | · | · | · | · | |
| Cash / Share | $2.38 | $1.55 | $1.47 | $1.66 | $10.85 | $8.51 | $4.87 | $12.63 | $5.07 | $1.12 | $1.05 | $0.93 | |
| EPS (TTM) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | · | 391,100,000 | 392,100,000 | 391,100,000 | · | 394,200,000 | 399,200,000 | 390,200,000 | · | 386,600,000 | 386,700,000 | 386,700,000 | · | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | · | 407,400,000 | 408,200,000 | 407,500,000 | · | 410,200,000 | 416,800,000 | 416,700,000 | · | 426,800,000 | 431,500,000 | 418,500,000 | · | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.95 | $7.66 | · | $6.99 | $6.56 | $5.78 | · | $5.07 | $6.08 | $5.67 | · | $5.87 | $5.44 | $5.76 | · | $4.72 | |
| Revenue / Share | $3.35 | $3.03 | · | $2.97 | $2.83 | $2.54 | · | $2.42 | $2.41 | $2.21 | · | $2.28 | $2.02 | $1.77 | · | $1.81 | |
| Cash Flow / Share | · | $1.34 | · | · | · | $0.45 | · | · | · | $0.50 | · | · | · | $0.37 | · | · | |
| Cash / Share | $2.93 | $2.90 | · | $4.71 | $2.96 | $2.31 | · | $1.59 | $2.34 | $2.15 | · | $1.67 | $3.09 | $1.61 | · | $1.81 | |
| EPS (TTM) | $2.52 | $2.33 | · | $1.79 | $1.43 | $1.33 | · | $1.66 | $1.61 | $1.54 | · | $0.92 | $0.87 | $0.71 | · | $0.16 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.97B | $4.82B | · | $4.52B | $4.30B | $4.15B | · | $3.95B | $3.93B | $3.80B | · | $3.40B | $3.20B | $3.02B | · | $2.79B | |
| Net Income TTM | $1000M | $930M | · | $721M | $572M | $535M | · | $681M | $667M | $639M | · | $377M | $358M | $292M | · | $244M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 26.7 | 27.0 | · | 37.6 | 61.0 | 51.3 | · | 40.4 | 70.4 | 90.1 | · | 101.4 | 147.7 | 163.6 | · | 503.4 | |
| P/S | 5.1 | 5.0 | · | 5.8 | 8.0 | 6.5 | · | 6.6 | 11.5 | 14.5 | · | 10.6 | 15.5 | 14.9 | · | 11.1 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| Earnings Yield | 3.7% | 3.7% | · | 2.7% | 1.6% | 1.9% | · | 2.5% | 1.4% | 1.1% | · | 0.99% | 0.68% | 0.61% | · | 0.20% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Margem Bruta % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Margem Operacional % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Lucro líquido | $836M | $576M | $542M | $341M | $217M |
| EPS Diluído | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Índice de Liquidez Seca | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.08B | $631M | $512M | $305M | $53M |
Investidores institucionais (13F) 1.078 declarantes · $29.5B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
1.078
Valor detido
$29.5B
Novas posições
125
Posições encerradas
97
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 125 (-42 vs trimestre anterior) | 97 (+5 vs trimestre anterior) | 401 (+31 vs trimestre anterior) | 365 (+14 vs trimestre anterior) | +13.2M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.257.066.468 | 49.074.378 | 11,03% | Ações |
| BlackRock, Inc. | $2.575.742.626 | 38.244.137 | 8,72% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.697.876.797 | 25.209.752 | 5,75% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.323.867.969 | 19.656.540 | 4,48% | Ações |
| STATE STREET CORP | $1.237.947.284 | 18.380.806 | 4,19% | Ações |
| Invesco Ltd. | $1.029.655.765 | 15.288.133 | 3,49% | Ações |
| BAILLIE GIFFORD & CO | $996.887.087 | 14.801.590 | 3,38% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $834.165.910 | 12.426.515 | 2,83% | Ações |
| ALLIANCEBERNSTEIN L.P. | $734.346.085 | 11.693.409 | 2,49% | Ações |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $612.059.728 | 9.746.174 | 2,07% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $574.325.172 | 8.527.471 | 1,95% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462.914.937 | 6.873.273 | 1,57% | Ações |
| NORGES BANK | $462.565.862 | 6.868.090 | 1,57% | Ações |
| UBS Group AG | $408.530.217 | 6.065.779 | 1,38% | Ações |
| Amundi | $377.395.039 | 5.603.490 | 1,28% | Ações |
| MORGAN STANLEY | $347.275.842 | 5.156.282 | 1,18% | Ações |
| AMERIPRISE FINANCIAL INC | $324.681.713 | 4.820.775 | 1,10% | Ações |
| Castle Hook Partners LP | $260.667.534 | 3.870.342 | 0,88% | Ações |
| GOLDMAN SACHS GROUP INC | $253.142.816 | 3.758.616 | 0,86% | Ações |
| FRANKLIN RESOURCES INC | $242.183.395 | 3.595.893 | 0,82% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $240.915.152 | 3.560.621 | 0,82% | Ações |
| CIBC Bancorp USA Inc. | $232.974.509 | 3.454.735 | 0,79% | Ações |
| JPMORGAN CHASE & CO | $232.690.154 | 3.325.095 | 0,79% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231.627.696 | 3.439.164 | 0,78% | Ações |
| NORTHERN TRUST CORP | $221.927.948 | 3.295.144 | 0,75% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $218.060.428 | 3.237.720 | 0,74% | Ações |
| BANK OF AMERICA CORP /DE/ | $213.068.756 | 3.163.604 | 0,72% | Ações |
| RAYMOND JAMES FINANCIAL INC | $207.976.113 | 3.087.990 | 0,70% | Ações |
| AMERICAN CENTURY COMPANIES INC | $206.860.340 | 3.071.423 | 0,70% | Ações |
| CIBC Private Wealth Group LLC | $195.665.945 | 2.907.801 | 0,66% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $183.859.102 | 2.729.905 | 0,62% | Ações |
| Legal & General Group Plc | $173.237.203 | 2.572.193 | 0,59% | Ações |
| JANUS HENDERSON GROUP PLC | $166.077.317 | 2.644.539 | 0,56% | Ações |
| DEUTSCHE BANK AG\ | $164.034.901 | 2.435.559 | 0,56% | Ações |
| Bank of New York Mellon Corp | $155.554.805 | 2.309.648 | 0,53% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $152.790.681 | 2.268.607 | 0,52% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $149.327.006 | 2.217.179 | 0,51% | Ações |
| Employees Provident Fund Board | $147.498.453 | 2.190.029 | 0,50% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $142.152.983 | 2.109.812 | 0,48% | Ações |
| ROYAL BANK OF CANADA | $137.011.000 | 2.034.290 | 0,46% | Ações |
| FMR LLC | $127.510.091 | 1.893.246 | 0,43% | Ações |
| Nuveen, LLC | $123.266.328 | 1.830.235 | 0,42% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $117.263.085 | 1.741.100 | 0,40% | Opção de venda |
| NOMURA HOLDINGS INC | $115.126.069 | 1.709.370 | 0,39% | Ações |
| AXA Investment Managers S.A. | $112.203.653 | 1.667.464 | 0,38% | Ações |
| BLAIR WILLIAM & CO/IL | $112.182.565 | 1.665.665 | 0,38% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $109.834.111 | 1.630.796 | 0,37% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $92.130.221 | 1.367.932 | 0,31% | Ações |
| DSM CAPITAL PARTNERS LLC | $91.537.742 | 1.359.135 | 0,31% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89.939.931 | 1.335.411 | 0,30% | Ações |
Executivos da empresa 61 insiders · 37 diretores · 26 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22 de Agosto de 2026 F | 418.908 | 2 | 0 | $1.001.761 |
| Andrew P Rasdal | President & CEO | 2 de Maio de 2006 M | 2.944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22 de Março de 2017 S | 8.452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15 de Maio de 2007 A | 26.255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10 de Setembro de 2021 S | 19.280 | 0 | 0 | $0 |
| Sadie Stern | EVP Chief People & Culture Off | 28 de Setembro de 2026 S | 123.478 | 0 | 2 | $-447.644 |
| Michael Jon Brown | EVP Chief Legal Compliance Off | 15 de Setembro de 2026 S | 99.885 | 0 | 7 | $-873.358 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 10 de Setembro de 2026 S | 146.828 | 0 | 1 | $-302.936 |
| Kevin R Sayer | Executive Chair | 20 de Agosto de 2026 S | 302.214 | 0 | 6 | $-8.303.410 |
| Jon Coleman | EVP, Chief Commercial Officer | 4 de Junho de 2026 S | 95.450 | 0 | 2 | $-722.628 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29 de Janeiro de 2025 S | 42.044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12 de Março de 2024 S | 66.641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18 de Dezembro de 2023 D | 48.949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18 de Dezembro de 2023 D | 58.469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24 de Novembro de 2023 S | 124.775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 9 de Novembro de 2023 S | 47.725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11 de Setembro de 2023 D | 48.453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10 de Março de 2023 D | 208.023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10 de Março de 2023 D | 50.908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 9 de Maio de 2022 S | 13.675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 9 de Março de 2022 D | 13.789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 9 de Setembro de 2021 S | 16.254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23 de Março de 2021 S | 6.654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 9 de Setembro de 2020 D | 34.784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11 de Março de 2020 S | 38.584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16 de Julho de 2018 S | 50.882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 9 de Março de 2017 M | 84.034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16 de Novembro de 2010 P | 3.387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16 de Agosto de 2010 A | · | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12 de Março de 2010 A | · | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12 de Março de 2010 A | · | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12 de Março de 2010 A | 18.741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19 de Maio de 2008 A | · | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24 de Março de 2008 A | 53.125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 2 de Novembro de 2007 A | 10.967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 2 de Agosto de 2007 A | · | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 9 de Março de 2007 A | · | 0 | 0 | $0 |
| Nicholas Augustinos | Conselheiro | 15 de Setembro de 2026 S | 29.293 | 0 | 2 | $-679.769 |
| Glenn S Boehnlein | Conselheiro | 10 de Setembro de 2026 A | 5.841 | 0 | 0 | $0 |
| Bridgette P Heller | Conselheiro | 12 de Agosto de 2026 S | 29.570 | 0 | 4 | $-277.672 |
| Mark G Foletta | Conselheiro | 3 de Agosto de 2026 S | 48.852 | 0 | 4 | $-627.183 |
| Albert Frederick Osterloh IV | Conselheiro | 28 de Maio de 2026 A | 8.691 | 0 | 0 | $0 |
| Euan A. Ashley | Conselheiro | 28 de Maio de 2026 A | 12.731 | 0 | 0 | $0 |
| Rimma Driscoll | Conselheiro | 28 de Maio de 2026 A | 17.319 | 0 | 0 | $0 |
| Kyle Malady | Conselheiro | 28 de Maio de 2026 A | 28.242 | 0 | 0 | $0 |
| Richard Alexander Collins | Conselheiro | 28 de Maio de 2026 A | 5.605 | 0 | 2 | $-389.410 |
| Renee D Gala | Conselheiro | 28 de Maio de 2026 A | 12.486 | 0 | 0 | $0 |
| Steven R Altman | Conselheiro | 28 de Maio de 2026 A | 5.565 | 0 | 0 | $0 |
| Karen M Dahut | Conselheiro | 8 de Maio de 2025 G | 17.779 | 0 | 0 | $0 |
| Eric Topol | Conselheiro | 8 de Maio de 2025 G | 380.545 | 0 | 0 | $0 |
| Barbara Kahn | Conselheiro | 18 de Maio de 2024 G | 22.575 | 0 | 0 | $0 |
| Jay S Skyler | Conselheiro | 18 de Maio de 2023 G | 63.348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Conselheiro | 1 de Setembro de 2016 S | 52.820 | 0 | 0 | $0 |
| Martin Doordan | Conselheiro | 1 de Junho de 2012 A | 39.633 | 0 | 0 | $0 |
| Donald A Lucas | Conselheiro | 19 de Maio de 2010 A | 16.448 | 0 | 0 | $0 |
| Donald L Lucas | Conselheiro | 15 de Março de 2010 S | 69.076 | 0 | 0 | $0 |
| Sean Carney | Conselheiro | 19 de Maio de 2008 A | 20.285 | 0 | 0 | $0 |
| Glen D Nelson | Conselheiro | 14 de Março de 2008 P | 170.654 | 0 | 0 | $0 |
| Kim D Blickenstaff | Conselheiro | 23 de Maio de 2007 A | 4.104 | 0 | 0 | $0 |
| Brenton Karl Ahrens | Conselheiro | 13 de Abril de 2006 A | 280.619 | 0 | 0 | $0 |
| Jorge A Valdes | · | 13 de Março de 2017 S | 10.442 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 132 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IHI · iShares Trust | 4,91% | 1.844.741 SH | 11 de Setembro de 2026 | Diário |
| JMID · Janus Detroit Street Trust | 2,74% | 7.762 NS | 31 de Julho de 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 2,12% | 527 NS | 31 de Julho de 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 2,04% | 4.976 NS | 31 de Julho de 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,96% | 948 NS | 31 de Julho de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,68% | 170.219 SH | 1 de Outubro de 2026 | Diário |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,59% | 374.143 SH | 1 de Outubro de 2026 | Diário |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,28% | 17.329 NS | 31 de Julho de 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,15% | 305.526 NS | 31 de Julho de 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 1,15% | 184.331 NS | 31 de Julho de 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,01% | 5.118 NS | 31 de Julho de 2026 | N-PORT |
| IWP · iShares Trust | 0,95% | 2.162.676 SH | 11 de Setembro de 2026 | Diário |
| QFLR · Innovator ETFs Trust | 0,93% | 58.151 NS | 31 de Julho de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,81% | 20.420 NS | 31 de Julho de 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,81% | 3.979 NS | 31 de Julho de 2026 | N-PORT |
| QNXT · iShares Trust | 0,62% | 2.014 SH | 11 de Setembro de 2026 | Diário |
| SDG · iShares Trust | 0,60% | 11.793 SH | 11 de Setembro de 2026 | Diário |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2.956.203 SH | 19 de Agosto de 2026 | Diário |
| QIDX · Spinnaker ETF Series | 0,55% | 2.575 NS | 31 de Julho de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,52% | 65.774 NS | 31 de Julho de 2026 | N-PORT |
| IYH · iShares Trust | 0,52% | 224.542 SH | 11 de Setembro de 2026 | Diário |
| COWZ · Pacer Funds Trust | 0,49% | 1.097.680 NS | 31 de Julho de 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 76.326 NS | 31 de Julho de 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,48% | 1.038.503 SH | 1 de Outubro de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 183.141 NS | 31 de Julho de 2026 | N-PORT |
| IMCG · iShares Trust | 0,45% | 213.189 SH | 11 de Setembro de 2026 | Diário |
| IXJ · iShares Trust | 0,41% | 203.560 SH | 11 de Setembro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,38% | 1.156.710 SH | 19 de Agosto de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,37% | 7.593 NS | 31 de Julho de 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23.742 SH | 19 de Agosto de 2026 | Diário |
| RECS · Columbia ETF Trust I | 0,27% | 187.634 NS | 31 de Julho de 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,25% | 8.362.213 SH | 19 de Agosto de 2026 | Diário |
| SIZE · iShares Trust | 0,24% | 12.297 SH | 11 de Setembro de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,24% | 16.587 NS | 31 de Julho de 2026 | N-PORT |
| IWR · iShares Trust | 0,24% | 1.572.597 SH | 11 de Setembro de 2026 | Diário |
| IMCB · iShares Trust | 0,23% | 45.160 SH | 11 de Setembro de 2026 | Diário |
| ESUM · Strategy Shares | 0,23% | 4.954 NS | 31 de Julho de 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.334.278 SH | 1 de Outubro de 2026 | Diário |
| ESLG · Strategy Shares | 0,20% | 561 NS | 31 de Julho de 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 43.412 SH | 11 de Setembro de 2026 | Diário |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 181.851 NS | 31 de Julho de 2026 | N-PORT |
| XOEF · iShares Trust | 0,18% | 485 SH | 11 de Setembro de 2026 | Diário |
| LRND · New York Life Investments ETF Trust | 0,18% | 8.712 NS | 31 de Julho de 2026 | N-PORT |
| CATH · Global X Funds | 0,15% | 23.840 NS | 31 de Julho de 2026 | N-PORT |
| QYLG · Global X Funds | 0,15% | 2.837 NS | 31 de Julho de 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,15% | 21.359 NS | 31 de Julho de 2026 | N-PORT |
| QTR · Global X Funds | 0,15% | 136 NS | 31 de Julho de 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,15% | 895 NS | 31 de Julho de 2026 | N-PORT |
| QYLD · Global X Funds | 0,15% | 141.287 NS | 31 de Julho de 2026 | N-PORT |
| QCLR · Global X Funds | 0,14% | 57 NS | 31 de Julho de 2026 | N-PORT |
| QRMI · Global X Funds | 0,14% | 246 NS | 31 de Julho de 2026 | N-PORT |
| QQQM · Invesco Exchange-Traded Fund Trust … | 0,14% | 1.734.337 SH | 1 de Outubro de 2026 | Diário |
| QQQ · Invesco QQQ Trust, Series 1 | 0,14% | 7.879.739 SH | 1 de Outubro de 2026 | Diário |
| QSIX · Pacer Funds Trust | 0,14% | 298 NS | 31 de Julho de 2026 | N-PORT |
| USXF · iShares Trust | 0,13% | 22.924 SH | 11 de Setembro de 2026 | Diário |
| QUAL · iShares Trust | 0,12% | 666.753 SH | 11 de Setembro de 2026 | Diário |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,11% | 20.921 NS | 31 de Julho de 2026 | N-PORT |
| GARP · iShares Trust | 0,11% | 40.229 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,11% | 7.089 NS | 31 de Julho de 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,11% | 10.730 NS | 31 de Julho de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,10% | 56.508 SH | 1 de Outubro de 2026 | Diário |
| ILCG · iShares Trust | 0,10% | 37.554 SH | 11 de Setembro de 2026 | Diário |
| AQLT · iShares Trust | 0,10% | 3.937 SH | 11 de Setembro de 2026 | Diário |
| IQSU · New York Life Investments ETF Trust | 0,10% | 3.878 NS | 31 de Julho de 2026 | N-PORT |
| IWF · iShares Trust | 0,10% | 1.441.625 SH | 11 de Setembro de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 8.929 SH | 1 de Outubro de 2026 | Diário |
| CHRI · Global X Funds | 0,10% | 93 NS | 31 de Julho de 2026 | N-PORT |
| DSI · iShares Trust | 0,09% | 58.749 SH | 11 de Setembro de 2026 | Diário |
| VUG · VANGUARD INDEX FUNDS | 0,09% | 4.943.048 SH | 19 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,09% | 499.383 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,09% | 23.598 NS | 31 de Julho de 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 603.971 SH | 19 de Agosto de 2026 | Diário |
| WRND · New York Life Investments ETF Trust | 0,08% | 100 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,08% | 31.150 NS | 31 de Julho de 2026 | N-PORT |
| EGLE · Global X Funds | 0,08% | 20 NS | 31 de Julho de 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,08% | 10 NS | 31 de Julho de 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,06% | 12.002 SH | 1 de Outubro de 2026 | Diário |
| TOPC · iShares Trust | 0,06% | 230 SH | 11 de Setembro de 2026 | Diário |
| XVV · iShares Trust | 0,06% | 4.446 SH | 11 de Setembro de 2026 | Diário |
| XRMI · Global X Funds | 0,06% | 333 NS | 31 de Julho de 2026 | N-PORT |
| XTR · Global X Funds | 0,06% | 32 NS | 31 de Julho de 2026 | N-PORT |
| XCLR · Global X Funds | 0,05% | 23 NS | 31 de Julho de 2026 | N-PORT |
| IVE · iShares Trust | 0,05% | 312.923 SH | 11 de Setembro de 2026 | Diário |
| XYLG · Global X Funds | 0,05% | 394 NS | 31 de Julho de 2026 | N-PORT |
| XYLD · Global X Funds | 0,05% | 19.868 NS | 31 de Julho de 2026 | N-PORT |
| IUSV · iShares Trust | 0,05% | 165.780 SH | 11 de Setembro de 2026 | Diário |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,05% | 66.672 SH | 1 de Outubro de 2026 | Diário |
| PBP · Invesco Exchange-Traded Fund Trust | 0,05% | 2.246 SH | 1 de Outubro de 2026 | Diário |
| TOV · EA Series Trust | 0,05% | 1.441 NS | 31 de Julho de 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,05% | 912 NS | 31 de Julho de 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 32.725 NS | 31 de Julho de 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 53.113 NS | 31 de Julho de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,05% | 19.478 NS | 31 de Julho de 2026 | N-PORT |
| IVV · iShares Trust | 0,05% | 4.868.303 SH | 11 de Setembro de 2026 | Diário |
| DFVX · Dimensional ETF Trust | 0,05% | 3.126 NS | 31 de Julho de 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 6.516 NS | 31 de Julho de 2026 | N-PORT |
| ILCB · iShares Trust | 0,05% | 7.544 SH | 11 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,05% | 120.564 NS | 31 de Julho de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5.338 SH | 30 de Setembro de 2026 | Diário |
| VOXP · Advisors Series Trust | 0,05% | 33 NS | 31 de Julho de 2026 | N-PORT |
| IVW · iShares Trust | 0,05% | 421.263 SH | 11 de Setembro de 2026 | Diário |
| IYY · iShares Trust | 0,05% | 16.523 SH | 11 de Setembro de 2026 | Diário |
| IWB · iShares Trust | 0,05% | 264.795 SH | 11 de Setembro de 2026 | Diário |
| SPUU · Direxion Shares ETF Trust | 0,05% | 1.456 NS | 31 de Julho de 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,05% | 9.285 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,05% | 67.183 NS | 31 de Julho de 2026 | N-PORT |
| IUSG · iShares Trust | 0,04% | 173.802 SH | 11 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,04% | 499.542 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,04% | 104.639 SH | 11 de Setembro de 2026 | Diário |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 297 SH | 1 de Outubro de 2026 | Diário |
| VOO · VANGUARD INDEX FUNDS | 0,04% | 10.024.256 SH | 19 de Agosto de 2026 | Diário |
| VV · VANGUARD INDEX FUNDS | 0,04% | 450.660 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,04% | 12.252.641 SH | 19 de Agosto de 2026 | Diário |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,04% | 146.079 SH | 19 de Agosto de 2026 | Diário |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 43.354 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 63.234 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 32.310 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,04% | 86.728 SH | 19 de Agosto de 2026 | Diário |
| HCMT · Direxion Shares ETF Trust | 0,04% | 2.682 NS | 31 de Julho de 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 1.068 SH | 11 de Setembro de 2026 | Diário |
| SPXL · Direxion Shares ETF Trust | 0,04% | 30.165 NS | 31 de Julho de 2026 | N-PORT |
| URTH · iShares, Inc. | 0,04% | 34.971 SH | 11 de Setembro de 2026 | Diário |
| TILT · FlexShares Trust | 0,03% | 8.908 NS | 31 de Julho de 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 121.058 SH | 11 de Setembro de 2026 | Diário |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,03% | 29.537 SH | 1 de Outubro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 28.890 SH | 1 de Outubro de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 323.858 SH | 19 de Agosto de 2026 | Diário |
| DYNF · BlackRock ETF Trust | 0,02% | 87.332 SH | 11 de Setembro de 2026 | Diário |
| USCL · iShares Trust | 0,02% | 5.063 SH | 11 de Setembro de 2026 | Diário |
| LGDX · Tidal Trust III | 0,01% | 229 NS | 31 de Julho de 2026 | N-PORT |
| CRBN · iShares Trust | 0,01% | 1.408 SH | 11 de Setembro de 2026 | Diário |
| PEVC · Pacer Funds Trust | 0,00% | 1 NS | 31 de Julho de 2026 | N-PORT |
DXCM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 36 analistas
COMPRA
Alvo mediano
$95.00
+11,3%
15 41,7%
Compra forte
16 44,4%
Compra
5 13,9%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
25 analistas · 2026-10-02Alvo médio $95.08 +11,4%
Agora
Preço atual $85.36
Mín$79.00
Média$95.08
Máx$115.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
Últimas notícias Notícias recentes mencionando esta empresa
DexCom (DXCM) Publica Perspectiva Otimista para 2026, Sobe 6,6%
Yahoo Finance · 4 meses, 2 semanas atrás
Os Analistas de Wall Street Estão Otimistas com as Ações da DexCom?
Yahoo Finance · 4 meses, 2 semanas atrás
DexCom (DXCM) Relata Receita de $1,19 Bilhão no 1º Trimestre de 2026, com Crescimento de 15%
Yahoo Finance · 4 meses, 3 semanas atrás
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,92
entrada
$64.82
R:R 1,92
BLUECHIP_DIP
Stop out
risco 1
recompensa 1,85
entrada
$65.02
R:R 1,85
RANGE
Stop out
risco 1
recompensa 4,99
entrada
$63.32
R:R 4,99
Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Jul 30, 2026